Singapore markets closed

Masimo Corporation (MASI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
87.68-0.71 (-0.80%)
At close: 04:00PM EDT
87.06 -0.62 (-0.71%)
After hours: 07:57PM EDT

Masimo Corporation

52 Discovery
Irvine, CA 92618
United States
949 297 7000

IndustryMedical Devices
Full-time employees4,000

Key executives

NameTitlePayExercisedYear born
Mr. Joseph E. KianiFounder, CEO & Chairman3.31MN/A1965
Mr. Micah YoungExec. VP & CFO1.13MN/A1979
Mr. Bilal MuhsinChief Operating Officer1.2MN/A1981
Mr. Thomas Samuel McClenahanExec. VP, Gen. Counsel & Corp. Sec.957.51kN/A1973
Mr. Tao Leopold LevyExec. VP of Bus. Devel.798.52kN/A1974
Mr. Paul HataishiSr. VP & Chief Accounting OfficerN/AN/A1975
Mr. Yongsam LeeExec. VP & Chief Information OfficerN/AN/A1965
Dr. Steven J. BarkerChairman of Scientific Advisory Board & Chief Science OfficerN/AN/A1945
Mr. Eli KammermanVP of Bus. Devel. & Investor RelationsN/AN/AN/A
Mr. Jon ColemanPres of Worldwide Sales, Professional Services & Medical AffairsN/AN/A1964
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and O3 regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as,, and Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Corporate governance

Masimo Corporation’s ISS governance QualityScore as of 28 September 2023 is 6. The pillar scores are Audit: 3; Board: 7; Shareholder rights: 7; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.